Diabetes Mellitus, Type 1 Clinical Trials in Seattle, Washington

4 studies are recruiting for diabetes mellitus, type 1 in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

    This investigator-initiated study will enroll about 30 adults 18 to 65 years of age with type 1 diabetes (T1D) who are using the Tandem t:slim X2 insulin pump or Tandem Mobi insulin pump with Control-IQ or Control-IQ+ technology ("Control-IQ" which will refer to either Control-IQ or Control-IQ+). T…

    Stage
    Not phased
    Ages
    18 to 65
    Site
    University of Washington, Seattle, Washington
    Locations
    3 in total
    Run by
    Jaeb Center for Health Research

    See if you can join NCT06880835 on ClinicalTrials.gov

  2. Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

    Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because …

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    University of Washington, Seattle, Washington
    Locations
    19 in total
    Run by
    Alessandro Doria

    See if you can join NCT06217302 on ClinicalTrials.gov

  3. Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

    This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes. This medication has been effective in reducing cardiovascular disease and diabetic kidney disease and improving glucose…

    Stage
    Phase 3
    Ages
    18 to 49
    Site
    University of Washington Medicine Diabetes Institute (UWMDI), Seattle, Washington
    Locations
    2 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT05819138 on ClinicalTrials.gov

  4. TrialNet Pathway to Prevention of T1D

    Rationale: The accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, and characterization of the…

    Stage
    Not phased
    Ages
    2 to 45
    Site
    Benaroya Research Institute, Seattle, Washington
    Locations
    22 in total
    Run by
    University of South Florida

    See if you can join NCT00097292 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.